• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    • Shutterstock AI and Michael Annino

    Strengthening pharma’s sustainability foundation

    New tools can help seamlessly integrate sustainability into R&D and production goals

    Be Sure To Read

    Vaccines of the future

    There is a new era of vaccinology in pharma's pipelines

    2024 pharma predictions: Therapeutic advances, manufacturing tech

    In our two-part series, leaders weigh in on what the pharma industry can expect in the coming year
    Pm2303 Hero 854x480 Cover Story

    Nevertheless, they persisted

    How drugmakers are fighting to keep reproductive health drugs available, safe and legal

    Anticipating AI regulations in pharma manufacturing

    In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation

    FDA decisions to watch in 2024   

    This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more

    5 Pharma changemakers

    The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry

    Genentech cancer drug shows promise in earlier DLBCL treatment

    In a phase 3 trial, Columvi plus chemo improved survival rates for patients with relapsed or refractory diffuse large B-cell lymphoma

    Novartis Factor B inhibitor grabs priority review in IgAN

    Fabhalta heads towards another indication with a phase 3 win in rare kidney disease

    Genentech ends $3B Adaptimmune T-cell collab

    The UK-based biotech received notice that the 2021 deal will be terminated in 180 days

    EMA finds no link between GLP-1 drugs and suicidal thoughts

    The review began in July 2023, after two patients in Iceland reported adverse events

    Exclusives

    Pharma events calendar

    Keep track of in-person industry events.

    Pharma Innovation Awards

    Now accepting submissions for 2024!

    Funny Pharm

    Submit your caption to cartoons created by award-winning artist Jerry King.

    Articles

    The latest content from industry thought leaders.

    Editors' (re)View

    Weekly takes on things going on in the pharma world.

    Navigating data integrity compliance

    Discover insights into FDA's Data Integrity Guidance and how to leverage the Cloud to achieve GMP compliance.

    A Paperless Future: How Blue Mountain Revolutionized Asset Management at AmplifyBio

    Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.

    Harnessing the Power of Industry 4.0 for Life Science

    Leverage the latest advancements in technologies to drive innovation and deliver improved patient outcomes.

    Innovate with confidence: Smoothing the path to successful mRNA manufacturing

    mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome...

    5 ways dust collectors help ensure a controlled environment when tableting APIs

    During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors...

    White paper: Stop sweating temperature excursions

    Advanced chemical indicators give you the peace of mind that comes from reliable insights into your supply chains.

    Excipient-based strategies to harness complex therapeutics

    Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.

    Bringing down the barriers to process monitoring in biopharma

    How modern process analytical technologies such as Raman spectroscopy can improve quality control
    Screen Shot 2023 09 06 At 11 17 20 Am

    Bridging the gap between R&D and GMP

    Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
    Pm Article Option 4

    7 challenges of NGS-based biomarkers

    Next generation sequencing has unprecedented power in biology, but has yet to reach its full potential in medicine

    AAM
    Generic

    Charting a sustainable path for generics

    Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting
    Contract Manufacturing

    INCOG Biopharma: Pedaling towards excellence

    The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology
    Contract Manufacturing

    Cellares: A disruptive impact on cell therapy

    The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

    Slideshows

    Quality & Risk

    [Slideshow] 5 steps to improve your contamination control strategy

    A robust contamination control strategy isn't merely a guideline, it's a necessity
    Microsoft Teams Image (7)
    Home

    [Slideshow] Pharma Manufacturing's essential reference guide

    Quick answers to all your pharma manufacturing questions
    Shutterstock 749369605
    Home

    [Slideshow] What keeps pharma up at night?

    13 pharma scaries….and solutions that offer reprieve